|
Past editions:
ESF 2012
ESF 2011
ESF
2010 |
Sponsor
Download brochure >>
|
|
CROS NT is an international Contract Research Organisation (CRO) specialized in clinical data services. Founded in 1992, CROS NT has completed over 800 studies and remains focused on biometrics services including clinical data management, biostatistics (analysis and programming), pharmacovigilance, medical writing and life science technology. CROS NT can also offer expert consultancy services on trial design, CDISC standards, DSMB review and regulatory submissions. With offices in Italy, Germany and the UK, CROS NT has retained 100% of its customers due to advanced internal governance and client relationships built on trust.
Contact Info:
Mary Wieder, Business Development & Marketing Associate
mary.wieder@crosnt.com
www.crosnt.com |
| |
|
|
Download brochure >>
|
|
ARITHMOS provides IT products and services to different industries but with a special focus on making the conduct of clinical trials faster and more efficient for Pharmaceutical, Biotech and Medical Device companies as well as CROs. The company provides products for ePRO, EDC, CTMS, Pharmacovigilance, eLearning, Data Visualisation and Project Governance. Services include data integration, computer system validation, hosting and HelpDesk.
Contact Info:
info@arithmostech.com
www.arithmostech.com |
| |
|
|
Download brochure >>
|
|
Kubo Recruitment focuses on sourcing talent for the Life Sciences sector by identifying only the best fit available. This is only possible through close working relationships and a level of service second to none. Our areas of recruitment focus are clinical research, clinical data management, statistics and programming, pharmacovigilance, medical affairs, clinical monitoring and IT while our services cover Contract & Interim, Executive Search and Contingent Recruitment.
Contact Info:
Rachel Keay, Head of Recruitment
rachel.keay@kuborecruitment.com
www.kuborecruitment.com.
|
|
|
|
|
 |
|
The Grünenthal Group
is an independent, family-owned, international
research-based pharmaceutical company headquartered in
Aachen, Germany. Building on its unique position in pain
treatment, its objective is to become the most
patient-centric company and thus to be a leader in therapy
innovation.
Grünenthal is one of the last five remaining
research-oriented pharmaceutical companies with headquarters
in Germany which sustainably invests in research and
development. Research and development costs amounted to
about 26 percent of revenues in 2012. Grünenthal’s research
and development strategy concentrates on selected fields of
therapy and state-of-the-art technologies. We are intensely
focused on discovering new ways to treat pain better and
more effectively, with fewer side-effects than current
therapies.
Altogether, the Grünenthal Group has affiliates in 26
countries worldwide. Grünenthal products are sold in more
than 155 countries. Today, approx. 4,400 employees are
working for the Grünenthal Group worldwide. In 2012,
Grünenthal achieved revenues of €973 mn.
More information:
www.grunenthal.com |
|
|
|
|
|
Sponsor
Patronage
Media
Partner
|
